Joint research on nucleic acid medicines for hard-to-treat and rare cancers

「During the fiscal year under review, we established a joint research department at the research institute of the Osaka International Cancer Center, Osaka Prefectural Hospital Organization, an incorporated local independent administrative agency. The department, named the Nitto Nucleic Acid Drug Discovery Joint Research Department, was established to develop new nucleic acid drugs, and began drug discovery research on nucleic acid drugs for novel molecularly targeted therapies and cancer immunotherapies for intractable and rare cancers.」